CVS Health Stock Rockets After Blockbuster Q3 Results, Raises Profit Outlook
In Wednesday’s earnings announcement, CVS Health (NYSE: CVS) beat expectations across the board. The pharmacy-and-insurance giant reported Q3 total sales of $102.9 billion and adjusted profit of $1.60 per share cvshealth.com gurufocus.com, handily exceeding consensus. Revenue was about $7.5 billion higher than a year ago, driven by volume gains and modest price increases. The results “exceeded Wall Street’s expectations,” according to the Associated Press timesunion.com. Management simultaneously hiked its full-year guidance: adjusted earnings are now seen at $6.55–$6.65 per share cvshealth.com timesunion.com. This marks CVS’s third profit outlook raise in 2025, reflecting confidence in its turnaround plan. Investors rewarded the news –